Nomura Asset Management Co. Ltd. Buys 8,425 Shares of Axon Enterprise, Inc $AXON

Nomura Asset Management Co. Ltd. increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 10.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 87,557 shares of the biotechnology company’s stock after purchasing an additional 8,425 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Axon Enterprise were worth $49,726,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. grew its stake in shares of Axon Enterprise by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 9,367,224 shares of the biotechnology company’s stock worth $5,319,928,000 after purchasing an additional 53,060 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Axon Enterprise by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 2,226,159 shares of the biotechnology company’s stock worth $1,265,657,000 after purchasing an additional 35,544 shares during the last quarter. Baillie Gifford & Co. grew its stake in shares of Axon Enterprise by 1,198.7% in the fourth quarter. Baillie Gifford & Co. now owns 1,642,578 shares of the biotechnology company’s stock worth $932,869,000 after purchasing an additional 1,516,099 shares during the last quarter. Norges Bank bought a new stake in shares of Axon Enterprise in the fourth quarter worth $515,764,000. Finally, Massachusetts Financial Services Co. MA grew its stake in shares of Axon Enterprise by 23.0% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 838,289 shares of the biotechnology company’s stock worth $476,089,000 after purchasing an additional 156,647 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In related news, Director Erika Nardini sold 198 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total value of $100,302.84. Following the transaction, the director owned 1,946 shares in the company, valued at $985,804.68. The trade was a 9.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Isaiah Fields sold 2,000 shares of the business’s stock in a transaction on Friday, May 22nd. The shares were sold at an average price of $400.00, for a total transaction of $800,000.00. Following the completion of the transaction, the insider owned 52,813 shares in the company, valued at approximately $21,125,200. The trade was a 3.65% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 2,355 shares of company stock worth $977,233 over the last quarter. Company insiders own 4.20% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of several analyst reports. The Goldman Sachs Group set a $535.00 price objective on shares of Axon Enterprise in a research note on Thursday, May 7th. Robert W. Baird set a $800.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 25th. JPMorgan Chase & Co. boosted their price objective on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Craig Hallum reissued a “buy” rating and issued a $820.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 25th. Finally, UBS Group reduced their price objective on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $712.75.

Axon Enterprise Price Performance

AXON stock opened at $448.72 on Monday. The firm has a market cap of $36.17 billion, a price-to-earnings ratio of 180.21, a PEG ratio of 8.16 and a beta of 1.45. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91. The company’s fifty day simple moving average is $407.53 and its 200 day simple moving average is $494.02.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.01. The business had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.91 million. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. Axon Enterprise’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.47 earnings per share. On average, analysts expect that Axon Enterprise, Inc will post 1.82 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.